Literature DB >> 11818141

On the shoulders of giants: p63, p73 and the rise of p53.

Annie Yang1, Mourad Kaghad, Daniel Caput, Frank McKeon.   

Abstract

The discoveries of the p53 homologs, p63 and p73, have both fueled new insights and exposed enigmas in our understanding of the iconic p53 tumor suppressor. Although the pivotal role of p53 in cancer pathways remains unchallenged, because p63 and p73 are now implicated in stem cell identity, neurogenesis, natural immunity and homeostatic control. Despite their seemingly separate tasks, there are hints that the p53 family members both collaborate and interfere with one another. The question remains, therefore, as to whether these genes evolved to function independently or whether their familial ties still bind them in pathways of cell proliferation, death and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818141     DOI: 10.1016/s0168-9525(02)02595-7

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  154 in total

1.  RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability.

Authors:  Jin Zhang; Seong Jun Cho; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  DeltaNp73beta is active in transactivation and growth suppression.

Authors:  Gang Liu; Susan Nozell; Hui Xiao; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

3.  Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity.

Authors:  Michael A Resnick; Alberto Inga
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

Review 4.  Transcriptional control of epidermal specification and differentiation.

Authors:  Xing Dai; Julia A Segre
Journal:  Curr Opin Genet Dev       Date:  2004-10       Impact factor: 5.578

5.  How many mutant p53 molecules are needed to inactivate a tetramer?

Authors:  Wan Mui Chan; Wai Yi Siu; Anita Lau; Randy Y C Poon
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

6.  Evaluation of p53, p63, p21, p27, ki-67 in paranasal sinus squamous cell carcinoma and inverted papilloma.

Authors:  Semih Oncel; Tulin Cosgul; Aylin Calli; Caglar Calli; Ercan Pinar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-11

Review 7.  Driving apoptosis-relevant proteins toward neural differentiation.

Authors:  Susana Solá; Márcia M Aranha; Cecília M P Rodrigues
Journal:  Mol Neurobiol       Date:  2012-07-01       Impact factor: 5.590

8.  A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis.

Authors:  Suwon Kim; Alana L Welm; J Michael Bishop
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

9.  Impaired repair of cyclobutane pyrimidine dimers in human keratinocytes deficient in p53 and p63.

Authors:  Bridget E Ferguson-Yates; Hongyan Li; Tiffany K Dong; Jennifer L Hsiao; Dennis H Oh
Journal:  Carcinogenesis       Date:  2007-11-04       Impact factor: 4.944

10.  Dipeptide analysis of p53 mutations and evolution of p53 family proteins.

Authors:  Qiang Huang; Long Yu; Arnold J Levine; Ruth Nussinov; Buyong Ma
Journal:  Biochim Biophys Acta       Date:  2013-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.